CIA vs GL
CIA: A niche life insurance provider focused on providing whole life, endowment, and final expense products to international and domestic customers. GL: Globe Life is a specialized provider of life and supplemental health insurance primarily serving the middle-income market.
Side-by-side fundamentals
| Metric | CIA | GL | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $3.53 | $166.08 | |
| Market cap as of 2026-07-31 (share count; price 2026-10-08) | $179M | $12.8B | |
| P/E as of 2026-10-08 | 9.81 | 11.03 | CIA lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | n/a | 0.69 | |
| Net margin FY2025, SEC XBRL | +5.7% | +19.4% | GL higher |
| Gross margin FY2023, SEC XBRL | n/a | +23.1% | |
| Operating margin FY2023, SEC XBRL | n/a | +23.2% | |
| ROE FY2025, SEC XBRL | +6.2% | +19.4% | GL higher |
| ROA FY2025, SEC XBRL | +0.8% | +3.8% | GL higher |
| Debt / equity as of 2026-09-03 | 0.00 | 0.48 | CIA lower |
| Revenue growth (YoY) as of 2026-09-03 | +6.9% | +5.2% | CIA higher |
| Revenue CAGR (3y) SEC XBRL | +3.2% | +4.7% | GL higher |
| Dividend yield as of 2026-09-03 | n/a | +0.8% | |
| Dividend streak (yrs) SEC XBRL | 0 | 14 | GL higher |
| Beta as of 2026-09-03 | 1.26 | 0.67 | |
| 1-year return as of 2026-10-08 close | -36.2% | +22.1% | GL higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.